ADAM17 and Alzheimer disease: Elevated levels of TNF-α, sTNFR1, and sTNFR2 in the cerebrospinal fluid and plasma are associated with Alzheimer’s disease (AD) and mild cognitive impairment (MCI), and higher TACE activity has been observed in both MCI and AD patients.